Label: ALLERGY RELIEF- cetirizine hcl 10 mg tablet

  • NDC Code(s): 69168-396-02, 69168-396-03, 69168-396-09, 69168-396-17, view more
    69168-396-30, 69168-396-43, 69168-396-60
  • Packager: Allegiant Health
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated December 12, 2019

If you are a consumer or patient please visit this version.

View All Sections
  • Active ingredient (in each tablet)

    Cetirizine HCl 10 mg

  • Purpose

    Antihistamine

  • Uses

    temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

    • runny nose
    • sneezing
    • itchy, watery eyes
    • itching of the nose or throat
  • Warnings

    Do not use if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing hydroxyzine

    Ask doctor if you have

    • liver or kidney disease. Your doctor should determine if you need a different dose.

    Ask doctor or pharmacist before use if you are

    taking sedatives or tranquilizers

    When using this product

    • drowsiness may occur
    • avoid alcoholic drinks
    • alcohol, sedatives, and tranquilizers may increase drowsiness
    • be careful when driving a motor vehicle or operating machinery

    Stop use and ask doctor

    if an allergic reaction to this product occurs. Seek medical help right away.

    If pregnant or breast feeding

    If pregnant or breast-feeding, ask a health professional before use.

  • Keep out of reach of children

    In case of accidental overdose, contact a octor or Poison Control Center (1-800-222-1222) right away.

  • Directions

    • Adults and children 6 years and over: one 10mg tablet once daily; do not take more than one 10mg tablet in 24 hours. A 5mg product may be appropriate for less severe symptoms
    • Adults 65 years and over: ask a doctor
    • Children under 6 years of age: ask a doctor
    • Consumers with liver or kidney disease: ask a doctor
  • Other information

    • store between 20°C to 25°C (68°F to 77°F)
    • do not use ifimprinted safety seal under cap is broken or missing
  • Inactive Ingredients

    colloidal silicon dioxide, croscarmellose sodium, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, titanium dioxide

  • Package/Label Principal Display Panel

    Allergy Relief

    Allergy Relief

  • INGREDIENTS AND APPEARANCE
    ALLERGY RELIEF 
    cetirizine hcl 10 mg tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:69168-396
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    CETIRIZINE HYDROCHLORIDE (UNII: 64O047KTOA) (CETIRIZINE - UNII:YO7261ME24) CETIRIZINE HYDROCHLORIDE10 mg
    Inactive Ingredients
    Ingredient NameStrength
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
    POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
    HYPROMELLOSES (UNII: 3NXW29V3WO)  
    LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  
    Product Characteristics
    ColorwhiteScore2 pieces
    ShapeRECTANGLE (pillow-shaped) Size9mm
    FlavorImprint Code G;4
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:69168-396-091 in 1 CARTON12/16/2014
    110 in 1 BLISTER PACK; Type 0: Not a Combination Product
    2NDC:69168-396-301 in 1 CARTON12/16/2014
    230 in 1 BOTTLE; Type 0: Not a Combination Product
    3NDC:69168-396-03250 in 1 BOTTLE; Type 0: Not a Combination Product12/16/2014
    4NDC:69168-396-6060 in 1 BOTTLE; Type 0: Not a Combination Product05/18/2022
    5NDC:69168-396-17300 in 1 BOTTLE; Type 0: Not a Combination Product05/31/2023
    6NDC:69168-396-4345 in 1 BOTTLE; Type 0: Not a Combination Product11/06/2023
    7NDC:69168-396-02150 in 1 BOTTLE; Type 0: Not a Combination Product11/06/2023
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA20927412/16/2014
    Labeler - Allegiant Health (079501930)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!